Key result
Low-risk PESI patients without right ventricle dysfunction markers had a significantly lower risk for adverse events than those with abnormal markers, though this did not apply to higher risk classes.
Answers are grounded in this paper and cite their sources.
Combining PESI scores with right ventricular dysfunction markers may improve risk stratification specifically in low-risk normotensive acute pulmonary embolism patients.
To the Editor : We read with great interest the paper by Sanchez et al. [1], in which the authors suggested that biomarkers and echocardiography findings would provide additional prognostic information to traditional risk models, such as the pulmonary embolism severity index (PESI), in normotensive acute pulmonary embolism (PE) patients. Patients were assigned to low- (PESI I–II), intermediate- (PESI III–IV) and high-risk classes (PESI V) and further stratified according to right ventricle dysfunction markers (right ventricle/left ventricle ratio, and troponin and brain natriuretic peptide (BNP) levels). The authors reported that low-risk PESI patients without any right ventricle dysfunction markers had a significantly lower risk for adverse events than low-risk patients with abnormal right ventricle/left ventricle ratio, troponin and/or BNP levels. However, the same results were not found for the remaining PESI classes (intermediate and high risk). Reliable risk stratification represents the cornerstone of PE management, which should be capable of recognising patients at high risk of death, who could receive specific therapeutic interventions, and those suitable for outpatient management, with important savings in healthcare costs. Although the PESI score has a proven high discriminative performance in the identification of low-risk patients, outperforming other validated PE risk models [2, 3], some authors have recently demonstrated that the 48-h recalculation of PESI can more accurately identify those eligible for outpatient management …
No takes yet. Share an insight, caveat, or question.
Paiva et al. (2013) conducted a letter in acute pulmonary embolism. Right ventricle dysfunction markers (RV/LV ratio, troponin, BNP) vs. Absence of right ventricle dysfunction markers was evaluated. Low-risk PESI patients without right ventricle dysfunction markers had a significantly lower risk for adverse events than those with abnormal markers, though this did not apply to higher risk classes.
Synapse has enriched 10 related papers. Consider them for comparative context: